Development of Therapeutic Products for Antibiotic Resistant Bacteria
$4,711,879N01FY2023AINIH
Venatorx Pharmaceuticals, Inc., Malvern PA
Investigators
Abstract
To support the advanced development of a promising candidate therapeutics. The research and development activities to be supported will allow the candidate therapeutic product to progress through the product development pathway, and include preclinical and IND enabling development activities, chemistry optimization/development, GMP manufacturing, and clinical safety and efficacy assessment.
View original record on NIH RePORTER →